etodolac , aspirin , and placebo were evaluated for efficacy and safety in 20 patients with adult-onset active rheumatoid arthritis who entered a 12-week , double-blind , parallel-group study divided into drug titration and maintenance periods and preceded by a two-week washout period .
C0004057
aspirin
C0003873
rheumatoid arthritis